Cambridge Healthtech Institute’s 23rd Annual

Recombinant Protein Expression and Production

January 20-21, 2021

 

The utilization of engineered therapeutic proteins for basic research, clinical diagnostics, and therapy continues to expand. While great strides have been made in the expression, production, and purification of these biomolecules, hurdles remain. The efficient expression and production of these valuable biomolecules face challenges in improving their quantity and quality while minimizing time and cost. Thus, higher-throughput expression and purification as well as more flexible expression platforms are in even greater demand. Unfortunately, there is no “universal” production system which can guarantee high yields of recombinant protein, particularly as every biomolecule itself causes its own issues in terms of expression.

 

Cambridge Healthtech Institute’s 23rd Annual Recombinant Protein Expression and Production conference explores the newest data and innovations relating to the best choices in hosts/systems, as well as ways to “rescue” existing systems and make them work more effectively to produce the quality and quantity of the desired biotherapeutic.

 

Coverage will include, but is not limited to:

 

  • Biotherapeutics
    • Recombinant Proteins
    • Antibodies
    • Vaccines
    • VLPs
    • Viral Vectors
    • Membrane Proteins
    • Difficult-to-Express Proteins
  • Cell Factories
    • Mammalian (CHO, HEK293, NS0)
    • Insect (Baculovirus, Drosophila)
    • Bacterial (Escherichia coli)
    • Yeast (Pichia pastoris, Saccharomyces cerevisiae)
    • Other (Algae, Tobacco)
  • Matching Host to Protein of Choice
  • Re‐Engineering Existing Systems for Better Performance
  • Automation for Higher Throughput
  • Faster Turnaround Times
  • Increasing Speed and Lowering Cost
  • Case Studies

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is July 24, 2020.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

If you are selected as a speaker for this virtual event, we request that you pre-record your presentation and be available during the “live” portion January 20-21 for interactive Q&A and panel discussions.

 

For more details on the conference, please contact:

Mary Ann Brown

Executive Director, Conferences

Cambridge Healthtech Institute

Phone: (+1) 781-972-5497 Email: mabrown@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K

Jason Gerardi

Senior Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-972-5452 Email: jgerardi@healthtech.com

 

Companies L-Z

Ashley Parsons

Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-1340 Email: ashleyparsons@healthtech.com